Nonalcoholic Fatty Liver Disease (NAFLD)

by

Tatjana Ábel, Gabriella Lengyel

DOI: 10.2174/97816810846571170101
eISBN: 978-1-68108-465-7, 2017
ISBN: 978-1-68108-466-4



Indexed in: EBSCO.

Non-alcoholic fatty liver disease (NAFLD) is a common cause of elevated liver enzymes and chronic liver disease in Western countries. ...[view complete introduction]
US $
Buy Personal eBook
69
Order Library eBook
276
Order Printed Copy
*119
Order PDF + Printed Copy (Special Offer)
*153

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Metabolic Diseases and NAFLD

- Pp. 103-118 (16)

Tatjana Ábel

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of elevated liver enzymes and chronic liver disease in the Western countries. NAFLD has been noted to be common in patients with obesity, hypertension, type 2 diabetes and atherogenic dyslipidemia. In the United States, it is estimated that NAFLD affects 20-30% of the general population. In patients with diabetes, the prevalence of NAFLD has been reported to be 70%. A high prevalence of NAFLD was found in patients with type 2 diabetes and obesity (90%). NAFLD is an independent predictor of future risk of cardiovascular diseases, and metabolic syndrome as well.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science